ATLASATLAS fair value
HK$0.801
Below fair value · 9% discount
Range: HK$0.515–HK$1.23Fair valuePrice
Sihuan Pharmaceutical (0460.HK)
Sihuan Pharmaceutical share price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Hong Kong Exchanges (HKEX) · Hong Kong SAR China
HK$0.730▲ 0.00%
Prices as of Oct 27, 2026 · HKD
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Sihuan Pharmaceutical in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Sihuan Pharmaceutical
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Sihuan Pharmaceutical's fair value at about HK$0.801 per share (reasonable range: HK$0.515 to HK$1.23). At HK$0.730, the stock trades 9% below it.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Sihuan Pharmaceutical a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between HK$0.674 and HK$0.786; in 9 out of 10, between HK$0.588 and HK$0.901. Estimated annual volatility is 42%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- HK$6.5B
- Market cap (USD)
- $831M
- P/E ratio
- 17.9
- Dividend yield
- 1.42%
- 52-week high
- HK$1.79
- 52-week low
- HK$0.685
- Revenue (12 months)
- CN¥2.6B
- Gross margin
- 65.6%
- Operating margin
- 19.6%
- Net margin
- 11.5%
- Beta
- 0.80
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Sihuan Pharmaceutical sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 0460.HK has traded between HK$0.685 and HK$1.79. Today it is 59.2% below that high and 7% above its low.
On the business: net margin is 11.5%; it trades at 17.9 times earnings.
Its beta is 0.80: it tends to move less than the market.
About the company
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China, the United States, and internationally.
Want to see everything about Sihuan Pharmaceutical?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Sihuan Pharmaceutical (0460.HK) fair value?
About HK$0.801 per share according to ATLAS (reasonable range: HK$0.515 to HK$1.23). With the stock at HK$0.730, it is 9% below it.
What is the chance 0460.HK goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, 0460.HK ends the month between HK$0.674 and HK$0.786.
How big is Sihuan Pharmaceutical and what is its P/E ratio?
Sihuan Pharmaceutical's market capitalization is HK$6.5B. Its price-to-earnings (P/E) ratio is 17.9: you pay HK$17.9 for each HK$1.00 of yearly earnings.
Does Sihuan Pharmaceutical pay a dividend?
Yes. 0460.HK's current dividend yield is 1.42% at today's price (HK$0.730).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer